CDC Financial’s Intapp INTA Stock Holding History

CDC Financial’s Portfolio INTA Stock Details INTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,918	Closed	-$537K	–	59
2026 Q1	$537K	Buy	+20,918	New	+$624K	0.34%	41

Other funds holding INTA

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CDC Financial's INTA Position: Q2 2026 in Review

CDC Financial sold out of Intapp (INTA) in Q2 2026, closing a stake of 20,918 shares — an estimated $537K sold.

CDC Financial first reported a position in INTA in Q1 2026 and held it in 1 quarter. The position peaked at $537K in Q1 2026. 249 funds tracked by Wall St. Rank hold INTA as of Q2 2026.

CDC Financial reported no remaining Intapp position as of Q2 2026 after selling out during the quarter.
CDC Financial sold 20,918 Intapp shares in Q2 2026, an estimated $537K.
CDC Financial first reported a position in Intapp in Q1 2026 and held it in 1 quarter.
CDC Financial's Intapp position peaked at $537K in Q1 2026.
249 funds tracked by Wall St. Rank held Intapp as of Q2 2026.

Based on CDC Financial's 13F filing for Q2 2026, filed 14 Aug 2026.